Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-017369
Filing Date
2022-05-09
Accepted
2022-05-09 21:29:39
Documents
2
Period of Report
2022-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1573
2 EX-24 DOCUMENT attachment1.htm EX-24 3646
  Complete submission text file 0000899243-22-017369.txt   6603
Mailing Address C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
FitzPatrick Margaret M (Reporting) CIK: 0001873879 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41331 | Film No.: 22907073

Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Issuer) CIK: 0001880438 (see all company filings)

IRS No.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations